SG/CALL/ASTRAZENECA/14000/0.1/20.09.24 Stock

Warrant

DE000SU6PYM3

Market Closed - Boerse Frankfurt Warrants 15:41:50 2024-05-17 EDT
0.15 EUR -6.25% Intraday chart for SG/CALL/ASTRAZENECA/14000/0.1/20.09.24
Current month-16.67%
1 month+76.47%
Date Price Change
24-05-17 0.15 -6.25%
24-05-16 0.16 -5.88%
24-05-15 0.17 -19.05%
24-05-14 0.21 0.00%
24-05-13 0.21 -8.70%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SU6PYM
ISINDE000SU6PYM3
Date issued 2024-01-08
Strike 14,000 p
Maturity 2024-09-20 (126 Days)
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.26
Lowest since issue 0.017
Delta0.18x
Omega 15.25
Premium16.77x
Gearing85.75x
Moneyness 0.8650
Difference Strike 1,890 p
Difference Strike %+13.50%
Spread 0.03
Spread %16.67%
Theoretical value 0.1650
Implied Volatility 21.91 %
Total Loss Probability 85.39 %
Intrinsic value 0.000000
Present value 0.1650
Break even 14,141.22 €
Theta-0.02x
Vega0.02x
Rho0.01x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
153.9 USD
Average target price
167.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW